Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandra Manceau

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
American Journal of Hematology|September 17, 2024
Clearance of pathogenic erythrocytes is maintained despite spleen dysfunction in children with sickle cell diseaseAbdoulaye Sissoko, Astan Cissé, Clémence Duverdier, et al.
American Journal of Hematology|October 25, 2025
Protein S Enhances the Phagocytosis of Phosphatidylserine-Exposing Erythrocytes: Implications in Sickle Cell DiseaseClaire Auditeau, Aurélie Fricot, Raphaël Gauthier, et al.
Hemasphere|December 25, 2025
MMS22L is a novel key actor of normal and pathological erythropoiesisElia Colin, Ivan Ferrer-Vicens, Dror Brook, et al.
Nature Communications|April 1, 2025
Severe inflammation and lineage skewing are associated with poor engraftment of engineered hematopoietic stem cells in patients with sickle cell diseaseSteicy Sobrino, Laure Joseph, Elisa Magrin, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
American Journal of Hematology|September 17, 2024
Clearance of pathogenic erythrocytes is maintained despite spleen dysfunction in children with sickle cell diseaseAbdoulaye Sissoko, Astan Cissé, Clémence Duverdier, et al.
American Journal of Hematology|October 25, 2025
Protein S Enhances the Phagocytosis of Phosphatidylserine-Exposing Erythrocytes: Implications in Sickle Cell DiseaseClaire Auditeau, Aurélie Fricot, Raphaël Gauthier, et al.
Hemasphere|December 25, 2025
MMS22L is a novel key actor of normal and pathological erythropoiesisElia Colin, Ivan Ferrer-Vicens, Dror Brook, et al.
Nature Communications|April 1, 2025
Severe inflammation and lineage skewing are associated with poor engraftment of engineered hematopoietic stem cells in patients with sickle cell diseaseSteicy Sobrino, Laure Joseph, Elisa Magrin, et al.
Pageof 3